This result is consistent with the high frequency of IL-21-producing T cells reported in both active and chronic parenchymal lesions of MS brain [26], and increased levels of IL-21 induced by anti-CD28 in CD4 from MS patients [27]. This evidence concerns the gene IL21 and myeloid sarcoma.